Aussie Research Leads To Possible Treatment For TB
This article was originally published in PharmAsia News
Executive Summary
Australian researchers say they have identified a basis for tuberculosis that could lead to the first new drug treatment in half a century. A research team at the Centenary Institute said a protein key to TB's survival has been identified, leading to a way to develop a drug to block it. TB is not a common threat in Australia, but it is in nearby island. The head of the research team said its discovery could lead to development of a drug that kills the responsible bacteria even as it lies dormant in the lungs. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.